AI in Healthcare

The landscape of drug discovery is undergoing a profound transformation, with artificial intelligence at its core. Recent findings highlight AI's critical role in tackling previously "undruggable" disease targets. Mayo Clinic researchers, for instance, leveraged AI-assisted screening to identify an experimental drug for pancreatic cancer, a significant leap forward, as reported by Drug Target Review on August 11, 2026. This capability to rapidly screen thousands of compounds and pinpoint effective inhibitors for complex proteins promises to accelerate the development of novel therapies and expand the horizon of treatable diseases. What are your thoughts on AI's impact on oncology and personalized medicine development? View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/linkedin/groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.
George Arnold Alexander III, MPA
Partner, ALEX Companies
Associate Broker, Alexander Tiffany Southwest, LLC
Licensed Broker in TX, CO, NC, AL
[email protected] · +1 713.918.9951
TREC Information About Brokerage Services · TREC Consumer Protection Notice
Download the PDFDownload the video
Slide 1Slide 2Slide 3Slide 4
Licensed by the Texas Real Estate Commission. Broker: Alexander Tiffany Southwest, LLC · License #565194-BB.
Diane Hart Alexander, Chair & CEO, ALEX Companies · Designated Broker · #574877-B  ·  George Arnold Alexander III, Partner, ALEX Companies · Associate Broker · #574878-B
Texas Real Estate Commission Information About Brokerage Services · TREC Consumer Protection Notice · trec.texas.gov